EDGAR Filing Documents for 0001193125-22-309120

Form 8-K - Current report:

SEC Accession No. 0001193125-22-309120

Filing Date

2022-12-20

Accepted

2022-12-20 16:01:40

Documents

Period of Report

2022-12-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d423117d8k.htm iXBRL	8-K	45153
2	EX-3.1	d423117dex31.htm	EX-3.1	12159
3	EX-10.1	d423117dex101.htm	EX-10.1	16670
4	EX-10.2	d423117dex102.htm	EX-10.2	19161
	Complete submission text file	0001193125-22-309120.txt		291963

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	pbax-20221216.xsd	EX-101.SCH	4779
6	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	pbax-20221216_def.xml	EX-101.DEF	15198
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	pbax-20221216_lab.xml	EX-101.LAB	25940
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	pbax-20221216_pre.xml	EX-101.PRE	16361
10	EXTRACTED XBRL INSTANCE DOCUMENT	d423117d8k_htm.xml	XML	7515

Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103

Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450

PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)